MAAB Group is a boutique healthcare investment firm founded by pharmaceutical industry veterans in 2011, focused on the commercialisation of innovative medical technologies and bridging Western innovation with Asian markets.

Headquartered in New Zealand, MAAB operates a lean, globally connected platform with an operational footprint in China, Denmark and the United Kingdom.

Through structured licensing, regulatory strategy and cross-border execution, MAAB works with pharmaceutical and medical technology innovators to bring niche and high-value healthcare products to markets in China and Australasia.

The company also partners with organisations seeking strategic options for their China assets, including licensing, distribution or divestment opportunities.

MAAB believes in building long-term partnerships with entrepreneurs, innovators and healthcare professionals to translate scientific innovation into real-world impact for patients.

Interested in working with MAAB? Get in touch.